215 related articles for article (PubMed ID: 32495883)
41. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
42. SNHG3 Functions as miRNA Sponge to Promote Breast Cancer Cells Growth Through the Metabolic Reprogramming.
Li Y; Zhao Z; Liu W; Li X
Appl Biochem Biotechnol; 2020 Jul; 191(3):1084-1099. PubMed ID: 31956955
[TBL] [Abstract][Full Text] [Related]
43. lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.
Eades G; Wolfson B; Zhang Y; Li Q; Yao Y; Zhou Q
Mol Cancer Res; 2015 Feb; 13(2):330-8. PubMed ID: 25253741
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-26a inhibits wound healing through decreased keratinocytes migration by regulating ITGA5 through PI3K/AKT signaling pathway.
Jiang Z; Wei J; Yang W; Li W; Liu F; Yan X; Yan X; Hu N; Li J
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32955094
[TBL] [Abstract][Full Text] [Related]
45. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
46. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
47. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/AKT activation in a ceRNA manner.
Zhang C; Yu Z; Yang S; Liu Y; Song J; Mao J; Li M; Zhao Y
Mol Cancer; 2024 Feb; 23(1):33. PubMed ID: 38355583
[TBL] [Abstract][Full Text] [Related]
48. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
49. MALAT-1: LncRNA ruling miR-182/PIG-C/mesothelin triad in triple negative breast cancer.
Barsoum FS; Awad AS; Hussein NH; Eissa RA; El Tayebi HM
Pathol Res Pract; 2020 Dec; 216(12):153274. PubMed ID: 33171372
[TBL] [Abstract][Full Text] [Related]
50. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
51. Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancer.
Kim Y; Ko JY; Lee SB; Oh S; Park JW; Kang HG; Kim DH; Chung D; Lim S; Kong H; Kim J; Yoo KH; Han W; Chun KH; Park JH
Oncogene; 2022 May; 41(22):3151-3161. PubMed ID: 35490208
[TBL] [Abstract][Full Text] [Related]
52. miR-506-loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple-negative breast cancer aggressiveness.
Liu XL; Liu WJ; Chen Q; Liu J; Yang CQ; Zhang G; Zhang SL; Guo WH; Li JB; Zhao G; Yin DC; Zhang CY
Mol Carcinog; 2021 Aug; 60(8):538-555. PubMed ID: 34062009
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
54. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.
Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F
Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834
[TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
Yan T; Ye XX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5139-5148. PubMed ID: 31298367
[TBL] [Abstract][Full Text] [Related]
57. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer.
Yang J; Qiu Q; Qian X; Yi J; Jiao Y; Yu M; Li X; Li J; Mi C; Zhang J; Lu B; Chen E; Liu P; Lu Y
Mol Cancer; 2019 Nov; 18(1):171. PubMed ID: 31779616
[TBL] [Abstract][Full Text] [Related]
59. Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway.
Wang L; Kang FB; Wang J; Yang C; He DW
Anticancer Drugs; 2019 Mar; 30(3):225-232. PubMed ID: 30334817
[TBL] [Abstract][Full Text] [Related]
60. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]